Post-earnings recap
Reported
Thu, Nov 7, 2024
EPS actual
$0.07
EPS est.
$-0.16
EPS surprise
+144.30%
1-day move
+0.00%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytomX Therapeutics reported a positive surprise on EPS, indicating better-than-expected earnings performance. However, there was no revenue reported, and the stock reaction remained unchanged at 0.00%. Investors will need to wait for further details from management to understand the implications of these results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.07 | N/A | +144.30% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.